Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 142.91
   
  • Change Today:
    $-1.72
  • 52 Week High: $155.80
  • 52 Week Low: $113.58
  • Currency: US Dollars
  • Shares Issued: 1,241.00m
  • Volume: 451,145
  • Market Cap: $177,351m
  • RiskGrade: 120
  • Beta: 0.01

Latest ShareCast News

Gilead Sciences to buy German biotech group Tubulis for up to $5bn

By Michele Maatouk

Date: Tuesday 07 Apr 2026

(Sharecast News) - California-based Gilead Sciences said on Tuesday that it has agreed to buy German clinical stage biotechnology group Tubulis for up to $5bn.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 142.91
Change Today $ -1.72
% Change -1.19 %
52 Week High $155.80
52 Week Low $113.58
Volume 451,145
Shares Issued 1,241.00m
Market Cap $177,351m
Beta 0.01
RiskGrade 120

What The Brokers Say

Strong Buy 8
Buy 15
Neutral 5
Sell 1
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-Oct-2026

Time Volume / Share Price
10:25 100 @ $142.91
10:25 155 @ $142.87
10:25 100 @ $142.87
10:25 108 @ $142.92
10:25 100 @ $142.92

Top of Page